Formulation and evaluation of rapidly disintegrating fenoverine tablets: Effect of superdisintegrants

Drug Development and Industrial Pharmacy

Volumn 33, Issue 11, 2007, Pages 1225-1232

  Battu, Sunil Kumar ^a   Repka, Michael A ^a,b   Majumdar, Soumyajit ^a,b   Madhusudan, Rao Y ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c KAKATIYA UNIVERSITY   (India)

Author keywords

Disintegration time; Dissolution; Rapidly disintegrating tablets; Superdisintegrants; Water absorption ratio; Wetting time

Indexed keywords

AEROSIL; ASPARTAME; BULKING AGENT; CROSCARMELLOSE SODIUM; CROSPOVIDONE; EXCIPIENT; FENOVERINE; FLAVORING AGENT; LUBRICATING AGENT; MICROCRYSTALLINE CELLULOSE; PEARLITOL; PEPPERMINT; POLYMER; STARCH GLYCOLATE SODIUM; STEARYL FUMARATE SODIUM; SWEETENING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG EFFICACY; DRUG FORMULATION; DRUG QUALITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; GROUPS BY AGE; HARDNESS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; PALATABILITY; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TABLET; TABLET COMPRESSION; TABLET DISINTEGRATION; TASTE; THICKNESS; TIME; WATER ABSORPTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; HUMANS; MALE; PHENOTHIAZINES; QUALITY CONTROL; SOLUBILITY; TABLETS; TASTE;

EID: 36749010777     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701377888     Document Type: Article

References (27)

1. Abdelbary, G., Eouani, C., Prinderre, P., Joachim, J., Reynier, J., & Piccerelle, P. (2005). Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int. J. Pharm., 292(1-2), 29-41.
2. Bi, Y., Sunada, H., Yonezawa, Y., Danjo, K., Otsuka, A., & Iida, K. (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharmaceut. Bull. (Tokyo), 44(11), 2121-2127.
3. Chang, R.-K., Guo, X., Burnside, B. A., & Couch, R. A. (2000). Fast-dissolving tablets. Pharm. Technol., 24(6), 52-59.
4. Fu, Y., Yang, S., Jeong, S. H., Kimura, S., & Park, K. (2004). Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit. Rev. Ther. Drug Carrier. Syst., 21(6), 433-476.
5. Gohel, M., Patel, M., Amin, A., Agrawal, R., Dave, R., & Bariya, N. (2004). Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm. Sci. Tech., 5(3), e36.
6. Gorman, E. A., Rhodes, C. T., & Rudnic, E. M. (1982). An evaluation of cros-carmellose as a tablet disintegrant in direct compression systems. Drug Dev. Ind. Pharm., 8, 397-410.
7. Hanawa, T., Watanabe, A., Tsuchiya, T., Ikoma, R., Hidaka, M., & Hidaka, M. (1995). New oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chem. Pharmaceut. Bull., 43(2), 284-288.
8. IBS. (2006a, February). Irritable bowel syndrome. NIH Publication 06-693.
9. ISP. (2006b, August 16). Crospovidone-International specialty products. Available: http://www.ispcorp.com/products/pharma/content/ brochure/polycros/.
10. James, K. (2003, May). Dissolution testing of orally disintegrating tablets. Dissolution Technol., 6-8.
11. Khan, K. A., & Rhodes, C. T. (1975). Water-sorption properties of tablet disintegrants. J. Pharm. Sci., 64(3), 447-451.
12. Kornblum, S. S., & Stoopak, S. B. (1973). A new tablet disintegrating agent: Cross-linked polyvinylpyrrolidone. J. Pharm. Sci., 62(1), 43-49.
13. Parakh, S. R., & Gothoskar, A. V. (2003, November). A review of mouth dissolving technologies. Pharm. Technol., 92-100.
14. Pharmeuropa. (1998). European directorate for the quality of medicines. Pharmeuropa (www.pheur.org), 10(1), 547.
15. Rossi, S., Sandri, G., & Caramella, C. (2005). Buccal drug delivery: A challenge already won? Drug Discovery Today: Technologies 2(1), 59-65.
16. Rowe, R. C., Sheskey, P. J., & Weller, P. J. (2003). Handbook of pharmaceutical excipients (4th ed., pp. 373-377). London: Pharmaceutical Press.
17. Saracco G, C. E. (1993). In Dobrosielski-Vergogna (Ed.), Biology of the salivary glands (pp. 11-14). Boca Raton: CRC Press.
18. Shiyosaku, K., Kiyo, M., & Kazumi, T. (1999). Quickly disintegrable solid preparation. JP 11130662, Japan.
19. Smart, J. D. (2004). Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity. Crit. Rev. Ther. Drug Carrier Syst., 21(4), 319-344.
20. Song, Y., Wang, Y., Thakur, R., Meidan, V. M., & Michniak, B. (2004). Mucosal drug delivery: Membranes, methodologies, and applications. Crit. Rev. Ther. Drug Carrier Syst., 21(3), 195-256.
21. Spasmopriv. (2006, September 12). Information for healthcare professionals. Available: http://www.spasmopriv.com/indexnieuws.htm
22. Suresh, B. B., David, O. H., & James, L. O. (2003). Quick dissolving films - A novel approach to drug delivery. Drug Deliv. Technol., 3(3), 63-66.
23. Virely, P., & Yarwood, R. (1990, February). Zydis - A novel, fast dissolving dosage form. Manufac. Chem. 36-37.
24. Wan, L. S. C., & Prasad, K. P. P. (1989). Uptake of water by excipients in tablets. Int. J. Pharm., 50, 147-153.
25. Wrong-diagnosis. (2006, August 17). Irritable bowel syndrome: NWHIC. Available: http://www.wrongdiagnosis.com/artic/ irritable_bowel_syndrome_nwhic.htm
26. Yen, S. Y., Chen, C. R., Lee, M. T., & Chen, L. C. (1997). Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants. Drug Dev. Ind. Pharm., 23(3), 313-317.
27. Zhao, N., & Augsburger, L. L. (2005). The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharm. Sci. Tech., 6(1), E120-126.